The oscillation for Acute Respiratory Distress Syndrome (ARDS) treated early (OSCILLATE) pilot study

ISRCTN ISRCTN42992782
DOI https://doi.org/10.1186/ISRCTN42992782
ClinicalTrials.gov number NCT00474656
Secondary identifying numbers MCT-82966
Submission date
31/05/2007
Registration date
31/05/2007
Last edited
06/04/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Maureen Meade
Scientific

McMaster University
Hamilton Health Sciences Centre, Rm. 2C9
1200 Main Street
Hamilton
Ontario
L8N 3Z5
Canada

Phone +1 (0)905 525 9140 ext. 22900
Email meadema@hhsc.ca
Dr Niall D Ferguson
Scientific

Toronto Western Hospital
399 Bathurst Street
F2-150
Toronto
M5T 2S8
Canada

Phone +1 (0)416 603 6203
Email n.ferguson@utoronto.ca

Study information

Study designRandomised parallel two-armed multicentre trial in therapeutic management strategy, with data analysts blinded
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleHigh frequency oscillation versus lung-protective ventilation using conventional ventilators to reduce Acute Respiratory Distress Syndrome (ARDS) mortality: a randomised, parallel, two armed, multicentre pilot trial
Study acronymOSCILLATE Pilot
Study objectivesThis is a pilot study to test the feasibility of a larger trial for which we hypothesise that high frequency oscillation will reduce acute respiratory distress syndrome (ARDS) mortality compared to lung-protective ventilation using conventional ventilators.
Ethics approval(s)Research Ethics Board of University Health Network, Toronto, Ontario (Canada), 03/05/2007, ref: 07-0158-B
Health condition(s) or problem(s) studiedAcute respiratory distress syndrome (ARDS)
Intervention1. High frequency oscillation (HFO): duration of mechanical ventilation
2. Lung open ventilation: duration of mechanical ventilation
Intervention typeOther
Primary outcome measure1. Feasibility at one-year of study. The three feasibility outcomes for the OSCILLATE pilot study will be evaluated as follows:
1.1. We will consider adherence to our explicit mechanical ventilation protocols to be adequate if more than 80% of patients (approximately 24/30) have fewer than 10% of monitored values (excluding crossover periods) as major protocol violations
1.2. We will consider the number of crossovers to be acceptable if fewer than 10% of patients cross over to the alternate ventilator, when not allowed by protocol
1.3. We will consider patient accrual to be adequate if we recruit 60 patients from 10 sites over one-year
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/05/2007
Completion date31/07/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants60
Key inclusion criteria1. Patients of either sex, 16 years and above
2. Acute onset of respiratory failure, with fewer than two weeks of new pulmonary symptoms
3. Endotracheal intubation or tracheostomy
4. Hypoxaemia: defined as a partial pressure of oxygen in arterial blood (PaO2)/fraction of inspired oxygen (FiO2) ratio of less than or equal to 200 mmHg
5. Bilateral alveolar consolidation (airspace disease) seen on frontal chest radiograph
Key exclusion criteria1. Remaining duration of mechanical ventilation less than 48 hours, as judged by the attending physician
2. Primary cause of acute respiratory failure judged by attending physician to be cardiac in origin
3. Lack of commitment to ongoing life support
4. Weight less than 35 kg
5. Severe chronic respiratory disease
6. Morbid obesity: defined as greater than 1 kg/cm body height
7. Neurological conditions with risk of intracranial hypertension (hypercapnia should be avoided)
8. Neuromuscular disease that will result in prolonged need for mechanical ventilation
9. Previous enrolment in this trial
10. All inclusion criteria present for greater than 72 hours
11. On high frequency oscillator (HFO) at the time of screening
Date of first enrolment01/05/2007
Date of final enrolment31/07/2008

Locations

Countries of recruitment

  • Canada

Study participating centre

McMaster University
Ontario
L8N 3Z5
Canada

Sponsor information

McMaster University (Canada)
University/education

c/o Mrs Peggy Austin
1200 Main Street West
Hamilton
Ontario
L8N 3Z5
Canada

Phone +1 (0)905 525 9140
Email austinp@mcmaster.ca
Website http://www.mcmaster.ca/
ROR logo "ROR" https://ror.org/02fa3aq29

Funders

Funder type

Research organisation

Canadian Institutes of Health Research (ref: MCT-82966)
Government organisation / National government
Alternative name(s)
Instituts de Recherche en Santé du Canada, Canadian Institutes of Health Research (CIHR), CIHR_IRSC, Canadian Institutes of Health Research | Ottawa ON, CIHR, IRSC
Location
Canada

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 28/02/2013 Yes No
Results article eligible nonenrolled patients results 01/12/2015 Yes No

Editorial Notes

06/04/2016: Publication reference added.